Zobrazeno 1 - 10
of 395
pro vyhledávání: '"L, Auquier"'
Publikováno v:
La Revue de Médecine Interne. 29:161-168
Autor:
Jean Baptiste Paolaggi, P. Ambroise-Thomas, L. Auquier, M. Bourel, D. Couturier, F. Dubois, B. Glorion, M. Huguier, A. Larcan, B. Launois, R. Mornex, C. Nézelof, J.B. Paolaggi, P. Pichot, P. Queneau, P. Rondot, J. Coste, Madame Estanove
Publikováno v:
Bulletin de l'Académie Nationale de Médecine. 188:803-811
Are we going to change the way we practice medicine? There are two kinds of medical knowledge: one is impersonal and results from research based on scientific methodology and scientific reasoning; the other is personal and results from learning and a
Publikováno v:
La Revue de medecine interne. 29(2)
We review the current knowledge about fibromyalgia, adding to the clinical aspects, the nosology, epidemiology and pathogenesis. The therapeutic and social management of these suffering patients are discussed.The limitations of the American College o
Autor:
L, Auquier
Publikováno v:
Bulletin de l'Academie nationale de medecine. 179(7)
Autor:
L, Auquier, J F, Cier
Publikováno v:
Bulletin de l'Academie nationale de medecine. 178(8)
Autor:
L, Auquier
Publikováno v:
Bulletin de l'Academie nationale de medecine. 178(3)
Autor:
L, Auquier
Publikováno v:
Bulletin de l'Academie nationale de medecine. 175(4)
Autor:
J F, Cier, L, Auquier
Publikováno v:
Bulletin de l'Academie nationale de medecine. 175(2)
Autor:
L, Auquier, J B, Paolaggi
Publikováno v:
Bulletin de l'Academie nationale de medecine. 174(2)
1. There is still controversy about polymyalgia rheumatica (PMR) and temporal arteritis (TA), either expressions of a single disease or two different conditions with overlapping. Nearly 50% of TA present with a PMR syndrome and 5% of PMR have a posit
Autor:
Pierre J. Marie, A. Julien, B. Argemi, L. Auquier, J.B. Eisinger, D. Kuntz, Philippe Bordier, Howard Rasmussen, F. Caulin, J. Gueris
Publikováno v:
Metabolic Bone Disease and Related Research. 2:107-111
Twenty-six patients with postmenopausal osteoporosis were randomly divided into three treatment groups and were then treated for a period of six months with either : 1) double placebo ; II) oral placebo and parenteral calcitonin ; or III) oral phosph